Pharmacogenetics of clozapine remission

Project Details

This project is aimed at the discovery of genomic, transcriptomic, and/or proteomic markers for clozapine mediated symptom remission with particular focus on the NRG1-ErbB pathway. In addition, we are exposing healthy peripheral blood mononuclear cells to clozapine for 24 hours and seven days to estimate acute and chronic effects of clozapine on NRG1-ErbB pathway gene and protein expression.

Funding

  • CRC for Mental Health

Research Group

Gene-Environment Neuropsychiatry (GENe)


Research Themes

Neuroscience

Areas of Excellence

Neuroscience and Psychiatry


Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

Psychiatry